New diabetes clinical trial: Treating the Metabolic Syndrome With a Sodium-glucose Cotransporter-2 Inhibitor: a Randomised Controlled Trial

Published on: July 14, 2025 at 11:00PM
Conditions: Metabolic Syndrome
Interventions: Drug: Empagliflozin (oral); Other: Matching placebo
Sponsors: The University of Hong Kong
Not yet recruiting
https://ift.tt/zD13AGV